Is CME a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for CME Group (CME) rests on Record trading volumes: Average daily volume hit a record 36.2 million contracts in Q1 2026, up 22 percent year over year with records across all six asset classes. Revenue (TTM) is ~$6.7B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Revenue is cyclical and tied to trading volumes, so a prolonged low-volatility environment can depress activity and fees. Whether CME is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
CME Group operates the largest futures and options marketplace in the world, spanning six asset classes: interest rates, equity indexes, energy, agricultural commodities, metals and foreign exchange. It earns money mainly from clearing and transaction fees charged on every contract traded and cleared, plus market-data and information-services revenue, and it benefits from owning both the exchange and the clearinghouse that guarantees trades. Volumes rise with hedging demand and market volatility, which is why record average daily volume has been the main engine of recent results. The investment picture is that of a wide-moat, capital-light franchise with operating margins near 65 to 70 percent and heavy free-cash-flow generation, which funds a regular quarterly dividend plus a variable year-end dividend that together produce a high headline yield. The trade-offs are a full valuation for an exchange, sensitivity to interest-rate activity and volatility cycles, and emerging competitive and regulatory threats (FMX in Treasury futures, perpetual-futures offerings from crypto venues) that could pressure the moat over time.
What's the case for buying CME?
1. Record trading volumes
Average daily volume hit a record 36.2 million contracts in Q1 2026, up 22 percent year over year with records across all six asset classes. Because CME earns a fee per contract, rising volume flows almost directly to revenue given the fixed-cost, capital-light model.
2. Interest-rate and volatility franchise
CME's interest-rate complex (SOFR, Treasury futures) is its largest product area and benefits from active rate markets and hedging demand. Periods of macro uncertainty and shifting central-bank policy tend to lift volumes, making CME a structural beneficiary of market volatility.
3. High margins and shareholder returns
Operating margins run near 65 to 70 percent, and the asset-light model converts revenue into substantial free cash flow. CME returns most of that cash through a regular quarterly dividend plus a variable year-end dividend, giving it an unusually high blended payout among large-cap financials.
4. New products and market data
CME continues to extend into event contracts, crypto derivatives, micro-sized contracts for retail, and growing market-data and information-services revenue. These add optionality and diversify the mix beyond the core institutional futures franchise.
What are the risks to CME?
Revenue is cyclical and tied to trading volumes, so a prolonged low-volatility environment can depress activity and fees. Competition is intensifying: FMX targets U.S. Treasury and SOFR futures with LCH clearing, ICE dominates Brent energy, and Cboe leans on VIX and options flow. A newer threat is regulated perpetual futures from crypto venues such as Coinbase and Kalshi, which the market fears could eventually breach the regulatory moat protecting high-margin retail products like 0DTE options. The stock also trades at a premium exchange multiple, so any volume slowdown or fee compression can weigh on the shares.
How is CME valued? (as of JULY 2026)
Snapshot for CME as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$6.7B
- FY2025 revenue: ~$6.5B
- Net income (TTM): ~$4.2B
- Market cap: ~$87B
- P/E (trailing): ~21x
- Dividend yield: ~4.6% (incl. variable)
CME posted record FY2025 revenue of about $6.5 billion and net income near $4.1 billion, then opened 2026 with record Q1 revenue of roughly $1.88 billion, up 14 percent, and adjusted EPS of $3.36. The shares trade around $240 for a market cap near $87 billion, a trailing P/E of roughly 21, with a high blended dividend yield reflecting the regular-plus-variable payout structure.
How do you decide if CME is a buy?
Rather than asking whether CME is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold CME indirectly through an index or sector ETF before adding more.
For the full picture, see the CME stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CME against your real portfolio and see your actual exposure before deciding.
The bottom line on CME
The bottom line: CME Group's story right now is Record trading volumes, with revenue (ttm) at ~$6.7B. If you believe that narrative continues, the call is about sizing CME sensibly and checking overlap with what you own; if you doubt it (the risk: revenue is cyclical and tied to trading volumes, so a prolonged low-volatility environment can depress activity and fees.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around CME with Walnut
Use CME Group as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is CME a good stock to buy right now?
+
The case for CME Group right now is Record trading volumes, with revenue (ttm) at ~$6.7B. If you believe that thesis holds, CME is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is revenue is cyclical and tied to trading volumes, so a prolonged low-volatility environment can depress activity and fees. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does CME Group do?
+
CME Group operates the largest futures and options marketplace in the world, spanning six asset classes: interest rates, equity indexes, energy, agricultural commodities, metals an
What are the main risks of CME?
+
Revenue is cyclical and tied to trading volumes, so a prolonged low-volatility environment can depress activity and fees. Competition is intensifying: FMX targets U.S. Treasury and SOFR futures with LCH clearing, ICE dominates Brent energy, and Cboe leans on VIX and options flow. A newer threat is regulated perpetual futures from crypto venues such as Coinbase and Kalshi, which the market fears could eventually breach the regulatory moat protecting high-margin retail products like 0DTE options. The stock also trades at a premium exchange multiple, so any volume slowdown or fee compression can weigh on the shares.
What does CME Group do?
+
CME Group operates the world's largest derivatives marketplace, running futures and options exchanges and a clearinghouse across six asset classes: interest rates, equity indexes, energy, agriculture, metals and foreign exchange. It earns fees on every contract traded and cleared, plus market-data revenue.
How does CME Group make money?
+
The bulk of revenue comes from clearing and transaction fees charged per contract, which reached about $1.54 billion in Q1 2026. The rest comes from market-data and information services, giving CME a mix of volume-driven and recurring subscription revenue.
What were CME Group's latest results?
+
In Q1 2026 CME reported record revenue of about $1.88 billion, up 14 percent, with net income of roughly $1.15 billion and adjusted EPS of $3.36. Average daily volume hit a record 36.2 million contracts, up 22 percent year over year.
How big is CME Group?
+
As of July 2026 CME trades near $240 per share for a market capitalization of roughly $87 billion. It generated about $6.5 billion in FY2025 revenue and around $4.1 billion in net income, making it one of the largest exchange operators globally.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell CME; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.